Prescription drug · NDA
Advair HFA NDC 50090-3672
fluticasone propionate and salmeterol xinafoate · Fluticasone propionate 115 ug/1; Salmeterol xinafoate 21 ug/1 · Aerosol, Metered · Respiratory (Inhalation) · A-S Medication Solutions
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 50090-3672-0 | 50090367200 | 1 INHALER in 1 CARTON (50090-3672-0) / 120 AEROSOL, METERED in 1 INHALERMarketed from Oct 16, 2018 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Advair HFA
- Generic name (nonproprietary)
- fluticasone propionate and salmeterol xinafoate
- Active ingredients
- Fluticasone propionate — 115 ug/1Salmeterol xinafoate — 21 ug/1
- Dosage form
- Aerosol, Metered
- Route
- Respiratory (Inhalation)
- Labeler
- A-S Medication Solutions
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 021254
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic beta2-Agonists (Mechanism)Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 50090-3672_60f8570f-0853-4add-ae12-6cb19839089dSPL ID 60f8570f-0853-4add-ae12-6cb19839089dSPL set ID 80b36523-4ae4-463e-b1fd-b929fb802b76RxCUI 896244, 896245UNII O2GMZ0LF5W, 6EW8Q962A5
- Pharmacologic class
- Corticosteroid; beta2-Adrenergic Agonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N450090367200followed by a unit qualifier and the quantityPackage 50090-3672-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
ADVAIR HFA is indicated for treatment of asthma in adult and adolescent patients aged 12 years and older. ADVAIR HFA should be used for patients not adequately controlled on a long-term asthma control medication such as an inhaled corticosteroid (ICS) or whose disease warrants initiation of treatment with both an ICS and long-acting beta 2 -adrenergic agonist (LABA). Limitations of Use ADVAIR HFA is not indicated for the relief of acute bronchospasm. ADVAIR HFA is a combination of fluticasone propionate, an inhaled corticosteroid, and salmeterol, a long-acting beta 2 ‑adrenergic agonist (LABA), indicated for treatment of asthma in adult and adolescent patients aged 12 years and older. ( 1 ) …
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 021254
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Advair HFAfluticasone propionate and salmeterol xinafoate | Fluticasone propionate 115 ug/1; Salmeterol xinafoate 21 ug/1 | Aerosol, MeteredRespiratory (Inhalation) | A-S Medication Solutions | 50090-4504 |
| Advair HFAfluticasone propionate and salmeterol xinafoate | Fluticasone propionate 45 ug/1; Salmeterol xinafoate 21 ug/1 | Aerosol, MeteredRespiratory (Inhalation) | GlaxoSmithKline LLC | 0173-0715 |
| Advair HFAfluticasone propionate and salmeterol xinafoate | Fluticasone propionate 115 ug/1; Salmeterol xinafoate 21 ug/1 | Aerosol, MeteredRespiratory (Inhalation) | GlaxoSmithKline LLC | 0173-0716 |
| Advair HFAfluticasone propionate and salmeterol xinafoate | Fluticasone propionate 230 ug/1; Salmeterol xinafoate 21 ug/1 | Aerosol, MeteredRespiratory (Inhalation) | GlaxoSmithKline LLC | 0173-0717 |
| Fluticasone Propionate and Salmeterol HFAfluticasone propionate and salmeterol xinafoate | Fluticasone propionate 230 ug/1; Salmeterol xinafoate 21 ug/1 | Aerosol, MeteredRespiratory (Inhalation) | Prasco Laboratories | 66993-088 |
| Fluticasone Propionate and Salmeterol HFAfluticasone propionate and salmeterol xinafoate | Fluticasone propionate 45 ug/1; Salmeterol xinafoate 21 ug/1 | Aerosol, MeteredRespiratory (Inhalation) | Prasco Laboratories | 66993-086 |
| Fluticasone Propionate and Salmeterol HFAfluticasone propionate and salmeterol xinafoate | Fluticasone propionate 115 ug/1; Salmeterol xinafoate 21 ug/1 | Aerosol, MeteredRespiratory (Inhalation) | Prasco Laboratories | 66993-087 |